Skip to main content
Vitrolife AB (publ) (STO:VITR)
Sweden flag Sweden · Delayed Price · Currency is SEK
105.10
-4.70 (-4.28%)
Apr 29, 2026, 1:00 PM CET

Vitrolife AB Revenue

Vitrolife AB had revenue of 807.00M SEK in the quarter ending March 31, 2026, a decrease of -4.16%. This brings the company's revenue in the last twelve months to 3.41B, down -5.68% year-over-year. In the year 2025, Vitrolife AB had annual revenue of 3.44B, down -4.68%.

Revenue (ttm)
3.41B
Revenue Growth
-5.68%
P/S Ratio
4.37
Revenue / Employee
3.02M
Employees
1,126
Market Cap
14.87B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20253.44B-169.00M-4.68%
Dec 31, 20243.61B97.00M2.76%
Dec 31, 20233.51B278.00M8.60%
Dec 31, 20223.23B1.55B92.39%
Dec 31, 20211.68B435.43M34.96%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Nolato AB 9.46B
Elekta AB 17.11B
Xvivo Perfusion AB 834.53M
MedCap AB 2.11B
Sectra AB 3.52B
Getinge AB 34.09B
CellaVision AB 730.59M
BICO Group AB 1.50B
Revenue Rankings

Vitrolife AB News

More News